ABBOTT LABORATORIES overview

Abbott Hosts Conference Call for Third-Quarter Earnings PR Newswire ABBOTT PARK, Ill., Sept. 23, 2021 ABBOTT PARK, Ill., Sept. 23, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2021 financial results on Wednesday, Oct. 20, 2021 , before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern), and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com...

Abbott Receives FDA Approval for Minimally Invasive Portico™ with FlexNav™ TAVR System to Treat Patients with Aortic Valve Disease - Transcatheter aortic valve replacement (TAVR) procedure treats people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery - With Portico approval, Abbott offers the industry's most comprehensive portfolio of structural heart solutions in the U.S. PR Newswire ABBOTT PARK, Ill., Sept. 20, 2021 ABBOTT PARK, Ill., Sept....

Abbott Declares 391st Consecutive Quarterly Dividend PR Newswire ABBOTT PARK, Ill., Sept. 15, 2021 ABBOTT PARK, Ill., Sept. 15, 2021 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 45 cents per share. This marks the 391 st consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 15, 2021, to shareholders of record at the close of business on Oct. 15, 2021 . Abbott has increased its dividend payout...

Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC Acquisition builds upon Abbott's leading vascular portfolio, adding mechanical thrombectomy devices for treating patients with peripheral blood clots PR Newswire ABBOTT PARK, Ill., Sept. 2, 2021 ABBOTT PARK, Ill., Sept. 2, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration...

Late-Breaking Data Shows Abbott's Amplatzer™ Amulet™ Occluder Offers Superior Left Atrial Appendage Closure Compared to Watchman‡ Device for People With Atrial Fibrillation at Risk of Stroke - New data presented at ESC Congress 2021 and simultaneously published in Circulation show Amulet Occluder was superior in left atrial appendage (LAA) closure and noninferior on safety and effectiveness endpoints compared to Watchman device - Amulet device is the first and only minimally invasive...

GUIDE-HF Study Data Show Abbott's CardioMEMS™ Device Can Improve Care for More Patients with Heart Failure - The GUIDE-HF study examined the potential impact of Abbott's CardioMEMS™ HF System, a small implantable pulmonary pressure sensor, in an expanded patient population not currently approved for the device - Data from the GUIDE-HF trial suggests CardioMEMS can improve care for more types of patients battling heart failure and reduce hospitalizations, especially for patients suffering...

Texas governor tested positive for coronavirus though he is fully vaccinated #FoxNews Subscribe to Fox News! https://bit.ly/2vaBUvAS Watch more Fox News ......

Texas Gov. Greg Abbott tested positive for Covid-19 despite being vaccinated. Abbott recently banned mask mandates despite opposition from local officials....

Abbott's Amplatzer™ Amulet™ Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke - Amulet is the first and only minimally invasive treatment option to offer immediate closure of the left atrial appendage (LAA), so blood-thinning medication isn't needed following implantation - The device helps to prevent blood clots from forming and leaving the LAA, reducing the risk of stroke in patients with atrial fibrillation, the most common sustained cardiac arrhythmia PR...

Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart - Ultreon™ 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using Artificial Intelligence - The new intuitive interface provides step-by-step guidance to enhance ease of use - When combined with Abbott's Dragonfly OpStar™ imaging catheter and PressureWire X™, the platform provides physicians with a...

Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management - FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app that allows users to check their glucose with a compatible iPhone[1] every minute with optional real-time glucose alarms[2] - The FreeStyle Libre 2 app enables kids (ages 4 and older) and adults to easily share their glucose data with parents and other caregivers via the LibreLinkUp[3] app - Free...

Texas Governor said he has a job to protect Texans, especially when it comes to Biden admin 'importing' COVID infected migrants. #FoxNews #Ingraham ......

VANCOUVER, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of the first amendment to its supplier distribution agreement between HealthTab™ Inc., a wholly owned subsidiary, and Abbott, the global healthcare company and diagnostics leader, in Canada. First signed on May 31 st of this year , the agreement allows the HealthTab™ to distribute in Canada Abbott’s...

Texas Gov. Greg Abbott criticizes President Biden and Democrats for misconstruing the meaning behind Texas' voting reform bill. #FoxNews Subscribe to Fox ......

Abbott Reports Second-Quarter 2021 Results - Sales growth of 39.5 percent; organic sales growth of 35.0 percent - GAAP diluted EPS from continuing operations growth of 120.0 percent; adjusted diluted EPS growth of 105.3 percent - Second-quarter sales, excluding COVID-19 testing-related sales, grew 12.3 percent on a reported basis and 11.3 percent on an organic basis compared to sales in 2019 - Achieved strong sales growth across all four major business areas - Full-year forecast continues to...